GetTopicDetailResponse(id=7239126090bc, topicName=KRAS G12C, introduction=, content=帕尼單抗 KRAS G12C 索托拉西布, image=null, comments=0, allHits=234, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Wed Apr 16 18:26:07 CST 2025, time=2025-04-16, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=114342, tagList=[TagDto(tagId=114342, tagName=KRAS G12C)], ipAttribution=, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2276931, encodeId=dda522e6931c8, content=<a href='/topic/show?id=2493130e1a1' target=_blank style='color:#2F92EE;'>#NSCLC#</a> <a href='/topic/show?id=7239126090bc' target=_blank style='color:#2F92EE;'>#KRAS G12C#</a>, objectTitle=J Clin Oncol：KRAS G12C陽性非小細(xì)胞肺癌患者單藥Divarasib長期隨訪結(jié)果, objectType=article, longId=891364, objectId=f6ea8913648a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250107/1736227021716_8538692.png, objectUrl=/article/show_article.do?id=f6ea8913648a, replyNumber=0, likeNumber=9, createdTime=2025-08-12, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f6ea8913648a, moduleTitle=J Clin Oncol：KRAS G12C陽性非小細(xì)胞肺癌患者單藥Divarasib長期隨訪結(jié)果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f6ea8913648a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2263867, encodeId=0c60226386e6b, content=<a href='/topic/show?id=493ae869206' target=_blank style='color:#2F92EE;'>#結(jié)直腸癌#</a> <a href='/topic/show?id=7239126090bc' target=_blank style='color:#2F92EE;'>#KRAS G12C#</a> <a href='/topic/show?id=b64e106e80cc' target=_blank style='color:#2F92EE;'>#索托拉西布#</a>, objectTitle=JCO：索托拉西布聯(lián)合帕尼單抗有望治療KRAS G12C突變的結(jié)直腸癌, objectType=article, longId=874970, objectId=78268e497086, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20250506/1746535657322_1938376.png, objectUrl=/article/show_article.do?id=78268e497086, replyNumber=0, likeNumber=20, createdTime=2025-05-07, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2260738, encodeId=efde2260e38f3, content=<a href='/topic/show?id=f9ba484920f' target=_blank style='color:#2F92EE;'>#帕尼單抗#</a> <a href='/topic/show?id=7239126090bc' target=_blank style='color:#2F92EE;'>#KRAS G12C#</a> <a href='/topic/show?id=b64e106e80cc' target=_blank style='color:#2F92EE;'>#索托拉西布#</a>, objectTitle=JCO | CodeBreaK 300 研究的總體生存分析：索托拉西布加帕尼單抗在化學(xué)難治性 KRAS G12C 結(jié)直腸癌中的應(yīng)用, objectType=article, longId=872140, objectId=43638e214076, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250415/1744721362707_6145188.png, objectUrl=/article/show_article.do?id=43638e214076, replyNumber=0, likeNumber=38, createdTime=2025-04-16, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43638e214076, moduleTitle=JCO | CodeBreaK 300 研究的總體生存分析：索托拉西布加帕尼單抗在化學(xué)難治性 KRAS G12C 結(jié)直腸癌中的應(yīng)用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=43638e214076)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-04-16
